ozu corporation (7487) Stock Price

Market cap
¥16.4B
P/E ratio
38x
Processes and sells specialized nonwoven fabrics for electronics, cosmetics, medical devices, and industrial applications to manufacturers worldwide.

Price and Volume

Market Cap

Subscribe to premium to access
Market Cap.

Check pricing

PER

Subscribe to premium to access
PER.

Check pricing

PBR

Business Overview

Ozutsu Industries Co., Ltd. primarily engages in the processing and sale of nonwoven fabric products. The company handles nonwoven fabrics for a wide range of applications including electronics, cosmetics, medical devices, industrial materials, and decontamination purposes, and conducts processing and manufacturing in collaboration with consolidated subsidiaries.

Major customers include electronics, cosmetics, and medical device manufacturers, as well as companies in industrial and agricultural sectors. Sales are conducted through manufacturing and processing subsidiaries, a sales office in China, and distributors. The company's revenue is centered on nonwoven fabric-related products, with additional revenue streams from real estate leasing, peracetic acid formulation sales, and household paper and consumer goods sales through equity method affiliates.

Operations are divided into two segments: the nonwoven fabric business and other businesses. The nonwoven fabric business maintains product lines by application—electronics, cosmetics, medical devices, industrial materials, and decontamination—with consolidated subsidiaries handling processing, manufacturing, and overseas sales. The other business segment includes real estate leasing, import and sale of peracetic acid formulations, and wholesale of household paper and consumer goods through affiliated companies.

Management Policy

The company has established a long-term vision called "OZU Innovation2034" and set a medium- to long-term target of consolidated net sales of 15 billion yen (1.5 times current levels). Under its first medium-term management plan (June 2024–May 2027), the company prioritizes building a solid foundation, with numerical targets of 105 billion yen in sales and 3 billion yen in operating profit during this period. Specifically, the company aims to expand by 3 billion yen through deepening existing businesses and 2 billion yen through new businesses, with strategic budget allocation toward talent acquisition, market research, and research and development to drive growth.

The company has identified priority investment areas including mechanical components and unit products for manufacturing sites in industrial sectors, hygiene materials and femcare/wellness products in medical and beauty fields, and environmental protection products. Differentiation is achieved not merely through trading functions but through transformation into "a trading company with capabilities to plan, develop, and manufacture products in-house." The company is leveraging the production capacity of its manufacturing subsidiary, Dipro Corporation, to expand its lineup of high-function nonwoven fabrics, wet products, and masks while improving quality and reducing costs.

To develop new markets and expand business, the company is exploring sectors including agriculture and fisheries, preventive medicine, home healthcare, disaster prevention, advanced technology, and environmental protection, in addition to deepening relationships with existing customers. A sales department reorganization implemented in June 2024 clarifies roles and strengthens outreach to Japanese companies abroad and intra-group collaboration, while actively pursuing partnerships and acquisitions for rapid business expansion. Specific initiatives include expanding sales of decontamination and oil-absorbent materials, strengthening peracetic acid formulations for food and livestock applications, and expanding agricultural products through Japan Plant Seeder.

The company positions technological innovation as key to growth and is strengthening efforts to collect both explicit and latent customer needs and translate them into product development and functionality. Through research and development investment and expanded manufacturing capabilities, the company is working to develop high-value-added materials and improve productivity, establishing competitive advantage by enhancing its ability to execute consistently from product planning through production. These are realistic initiatives that also consider external partnerships and technology acquisition through M&A, aiming to strengthen the earnings foundation over the medium to long term despite limited near-term profit contribution.

AI Chat